Europe — EMA
Grandise
Grandise contains granisetron hydrochloride, an oral 5‑HT3 antagonist used to prevent chemotherapy‑ and postoperative‑induced nausea and vomiting.
Request sourcing
What is Granisetron Hydrochloride?
Grandise is an oral medication that contains the active ingredient granisetron hydrochloride. It is supplied in a prescription‑only format and marketed in the European Union. Granisetron belongs to the 5‑HT3 receptor antagonist class and is used as an antiemetic to help control nausea and vomiting. The product is formulated for systemic absorption after swallowing and does not contain additional active strengths listed or dosage variations.
What is Granisetron Hydrochloride used for?
Grandise is indicated for the prevention of nausea and vomiting associated with specific medical procedures.
- Prevention of chemotherapy‑induced nausea and vomiting (CINV). - Prevention of postoperative nausea and vomiting (PONV). - Use as part of a multimodal antiemetic regimen in high‑risk patients. - May be employed when other 5‑HT3 antagonists are not suitable. - Suitable for adult patients undergoing moderately or highly emetogenic chemotherapy.
What are the side effects of Granisetron Hydrochloride?
The safety profile of granisetron hydrochloride includes both frequent, mild reactions and rare, more serious events.
Common: - Headache. - Constipation. - Fatigue. - Dizziness. - Diarrhea.
Serious: - Severe allergic reaction (anaphylaxis). - Cardiac arrhythmia. - QT interval prolongation. - Serotonin syndrome when combined with serotonergic agents.
What precautions apply to Granisetron Hydrochloride?
Before prescribing Grandise, clinicians should evaluate several safety considerations to minimize risk.
- Assess cardiac history, especially QT prolongation risk. - Review concomitant medications that affect heart rhythm. - Use caution in patients with hepatic impairment. - Monitor for signs of hypersensitivity during initial doses. - Adjust dose or avoid use in severe renal dysfunction. - Consider pregnancy and breastfeeding status, although data are limited.
What does Granisetron Hydrochloride interact with?
Granisetron may interact with other drugs, requiring attention to avoid adverse effects.
Avoid: - Other 5‑HT3 antagonists (duplicate therapy). - Drugs known to prolong QT interval (e.g., certain antiarrhythmics, macrolide antibiotics).
Use with caution: - Serotonergic agents such as SSRIs, SNRIs, or tramadol. - Antifungal azoles (e.g., ketoconazole). - Certain antipsychotics (e.g., haloperidol).
Frequently asked questions
What is the mechanism of action of granisetron hydrochloride in Grandise?+
Can Grandise be used for nausea caused by radiation therapy?+
Is Grandise available over the counter in the European Union?+
How should Grandise be taken to achieve optimal antiemetic effect?+
What are common side effects patients may notice after taking Grandise?+
Are there any serious adverse reactions associated with Grandise?+
Should patients with a history of heart rhythm problems avoid Grandise?+
Can Grandise be taken together with other antiemetic medications?+
What monitoring is recommended for patients on Grandise?+
Is Grandise safe for use during pregnancy or breastfeeding?+
How does renal impairment affect the use of Grandise?+
What should a patient do if they miss a dose of Grandise?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo